Here are four things to know:
1. The published article addresses areas relevant to serum-derived bovine immunoglobulin/protein isolate, including medical food management of functional bowel conditions with associated chronic loose and frequent stools. The article also addresses how SBI positively addresses specific symptoms and its impact in people with IBS-D.
2. EnteraGam was also mentioned in a recent Medscape article titled “Mixed Opioid Agent Adds to Growing List of Therapies for IBS-D.”
3. EnteraGam is a prescription medical food product intended to provide nutritional requirements that are unique for the clinical dietary management of specific intestinal disorders such as IBS-D, IBD and HIV-associated enteropathy.
4. Entera Health is a developer of clinically safe biotherapeutics based in Cary, N.C.
More articles on GI & endoscopy:
Gastroenterologist to know: Dr. John T. Lamont of Beth Israel Deaconess Medical Center
Gastroenterologist to know: Dr. Samir Gupta of University of California San Diego
5 most read GI/endoscopy stories: Week of March 28 – April 1
